Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 27;48(1):47-59.
doi: 10.5051/jpis.2018.48.1.47. eCollection 2018 Feb.

Clinical and microbiological effects of egg yolk antibody against Porphyromonas gingivalis as an adjunct in the treatment of moderate to severe chronic periodontitis: a randomized placebo-controlled clinical trial

Yan Xu  1   2 , Tshepiso Selerio-Poely  1   2 , Xingru Ye  1   2
Affiliations

Clinical and microbiological effects of egg yolk antibody against Porphyromonas gingivalis as an adjunct in the treatment of moderate to severe chronic periodontitis: a randomized placebo-controlled clinical trial

Yan Xu et al. J Periodontal Implant Sci. .

Abstract

Purpose: To evaluate the clinical and microbiological effects of the local use of egg yolk immunoglobulin against Porphyromonas gingivalis (anti-P.g. IgY) as an adjunct to scaling and root planing (SRP) in the treatment of moderate to severe chronic periodontitis.

Methods: This was a randomized, placebo-controlled, double-blind trial involving 60 systematically healthy patients with moderate to severe chronic periodontitis. Subjects (n=20/group) were randomly assigned to receive SRP combined with subgingival irrigation of anti-P.g. IgY and anti-P.g. IgY mouthwash, subgingival irrigation of 0.2% chlorhexidine and 0.2% chlorhexidine mouthwash, or subgingival irrigation of placebo and placebo mouthwash for 4 weeks. Probing pocket depth, clinical attachment level, bleeding on probing, and the plaque index were evaluated at baseline and at 4 weeks. Subgingival plaque, gingival crevicular fluid, and saliva were simultaneously collected for microbiological analysis.

Results: Our results showed that anti-P.g. IgY mouthwash was as effective as chlorhexidine at improving clinical parameters over a 4-week period. All the groups showed a significant reduction in levels of P.g. at 4 weeks. No significant difference was observed in the test group when compared to placebo regarding the reduction in the levels of P.g. Anti-P.g. IgY significantly suppressed the numbers of red complex bacteria (RCB) in subgingival plaque and saliva in comparison with placebo. No adverse effects were reported in any of the subjects.

Conclusions: Within the limitations of the study, the present investigation showed that passive immunization with anti-P.g. IgY may prove to be effective in the treatment of chronic periodontitis due to its ability to improve clinical parameters and to reduce RCB. No significant differences were found between the anti-P.g. IgY and placebo groups in the reduction of P.g.

Keywords: Chlorhexidine; Passive immunization; Periodontitis; Porphyromonas gingivalis; Therapeutics.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1
Flow diagram of the study. SRP: scaling and root planing, anti-P.g. IgY: egg yolk immunoglobulin against Porphyromonas gingivalis.
Figure 2
Figure 2
Box blots showing the percentages of each periodontopathic bacterium in the total bacteria at baseline and 4 weeks. (A) Porphyromonas gingivalis. (B) Tannerella forsythia. (C) Treponema denticola. Anti-P.g. IgY: egg yolk immunoglobulin against Porphyromonas gingivalis. a)Statistically significant intragroup difference compared to baseline (Wilcoxon signed-rank test).
Figure 3
Figure 3
Comparison in the number of RCB at baseline and 4 weeks in (A) subgingival plaque, (B) gingival crevicular fluid, and (C) saliva. RCB: red complex bacteria, anti-P.g. IgY: egg yolk immunoglobulin against Porphyromonas gingivalis, BANA: N-Benzoyl-DL-arginine-naphthylamide. a)Statistically significant intragroup difference compared to baseline; b)Statistically significant difference between the different treatment groups.
See this image and copyright information in PMC

References

    1. Sanz M, van Winkelhoff AJ. Periodontal infections: understanding the complexity--consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol. 2011;38(Suppl 11):3–6. - PubMed
    1. Corbet EF, Leung WK. Epidemiology of periodontitis in the Asia and Oceania regions. Periodontol 2000. 2011;56:25–64. - PubMed
    1. Dye BA. Global periodontal disease epidemiology. Periodontol 2000. 2012;58:10–25. - PubMed
    1. Grenier D, Mayrand D. Periodontitis as an ecological imbalance. In: Kuramitsu HK, Ellen RP, editors. Oral bacterial ecology: the molecular basis. Wymondham: Horizon Scientific; 2000. pp. 275–310.
    1. Slots J, Ting M. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000. 1999;20:82–121. - PubMed

LinkOut - more resources